Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Unknown 2Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 16Lymphoma 7Neoplasms, Plasma Cell 5Lymphoma, Large B-Cell, Diffuse 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Melanoma 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Waldenstrom Macroglobulinemia 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, B-Cell, Marginal Zone 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Burkitt Lymphoma 2Skin Neoplasms 1Sezary Syndrome 1Sarcoma, Ewing 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Topotecan 2Ifosfamide 2Etoposide 2trioctyl phosphine oxide 1indolepropanol phosphate 1imetelstat 1Vincristine 1Transplantation 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Minocycline 1Melphalan 1Heparin 1Glutamine 1GRN163L peptide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neuroectodermal Tumors, Primitive, Peripheral × Melphalan × Clear all
NCT01795430 2015-01-09

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

City of Hope Medical Center

Phase NA Withdrawn

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡